Answers are grounded in this paper and cite their sources.
Self-expandable metal stents (SEMS) are commonly used to treat malignant biliary obstruction (MBO). External plastic stent anchoring for fully covered SEMS (FCSEMS-EPS) has shown potential to improve stent patency; however, randomized evidence comparing this strategy with uncovered SEMS (USEMS) is limited. This multicenter trial was conducted at nine tertiary referral centers in South Korea. Patients were enrolled from October 2021 to February 2024 and followed for 12 months after stent placement. Those with unresectable distal MBO were randomly assigned (1:1) to receive either FCSEMS-EPS or USEMS. The primary outcome was biliary stent dysfunction. Time-to-event analyses were performed using time to stent dysfunction within a competing risk framework. 113 patients were enrolled, of whom 99 were included in the final analysis (FCSEMS-EPS 48; USEMS 51). Stent dysfunction occurred less frequently in the FCSEMS-EPS group compared with the USEMS group (27.1% vs. 49.0%; P = 0.04). The cumulative incidence of stent dysfunction at 6 months was lower in the FCSEMS-EPS group (21.1% vs. 29.8%; Gray’s test, P = 0.03). In multivariable competing risk analysis, FCSEMS-EPS was independently associated with a lower risk of stent dysfunction (subdistribution hazard ratio 0.44, 95%CI 0.21–0.90; P = 0.03). Procedure-related adverse events and overall survival did not differ between groups. FCSEMS-EPS significantly reduced stent dysfunction compared with USEMS without increasing adverse events, supporting its effectiveness and safety as long-term biliary drainage in unresectable MBO.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: